Status:

UNKNOWN

Bioequivalence Study of Prednisolone and Dexamethasone

Lead Sponsor:

University Medical Center Groningen

Conditions:

Healthy Volunteers

Eligibility:

All Genders

18-75 years

Phase:

PHASE1

Brief Summary

The purpose of this study is to compare two different glucocorticoids, prednisolone and dexamethasone at two different doses for their organ specific effects, utilizing modern day standards.

Detailed Description

Study design: A randomised, double blind, cross-over clinical trial. Study population: healthy human adult volunteers including 12 males and 12 females aged 18-75 years old. Intervention: In random ...

Eligibility Criteria

Inclusion

  • Participants must be healthy with no relevant medical history and no use of medication.
  • Female participants aged \<50 years must be using oral contraceptives and female participants age ≥50 years must be in the postmenopausal state
  • Command of the Dutch language
  • Providing written IC
  • BMI between 18.5 and 30 kg/m2
  • Participants must be between 18 and 75 years of age

Exclusion

  • Potential participants who are unlikely to adhere to the study protocol (for instance subjects which have a history of substance abuse or non-compliance)
  • Potential participants with a medical history of:
  • Diseases affecting the HPA-axis: e.g. primary and secondary adrenal insufficiency, pituitary tumors, and nightshift workers
  • Diseases affecting the HPG-axis: e.g. Cushing disease.
  • Chronic inflammatory diseases: e.g. rheumatoid arthritis, polymyalgia rheumatic, and asthma
  • Psychiatric diseases
  • Diabetes
  • Shift workers
  • Potential participants with a kidney function \<60 ml/min/1.73m2, abnormalities in liver enzymes, and/or abnormalities in thyroid function
  • Potential participants who are dependent on corticosteroids, e.g. asthmatic patients, and transplant recipients

Key Trial Info

Start Date :

March 4 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 31 2022

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04733144

Start Date

March 4 2021

End Date

May 31 2022

Last Update

April 12 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University Medical Center Groningen

Groningen, Netherlands, 9713 GZ